Share this article
Share this article
NEW YORK, Jan. 11, 2021 /PRNewswire/ Life sciences mergers and acquisitions (M&A) activity totaled US$159b in 2020, down from US$306b in 2019, reaching one of the lowest levels since 2014, according to the 2021 EY
, launched today. A single megadeal – AstraZeneca s December purchase of Alexion Pharmaceuticals – accounted for a quarter of the annual life sciences M&A spend. Setting aside the challenges of doing diligence and closing deals virtually due to the COVID-19 pandemic, persistently high valuations for biopharma and medtech targets kept many would-be buyers on the sidelines, in what was already expected to be a difficult year. In this unfavorable environment, biopharma acquirers refocused their energy on alliances and smaller, bolt-on deals in high-priority therapeutic areas. Medtechs experienced revenue slowdowns due to the cancellation or deferment of procedures in 2020.
Qualitas Health/iwi Raises $10M in First Close of New Investment Round
USA - English
News provided by
Share this article
Share this article
HOUSTON, Jan. 11, 2021 /PRNewswire/ Plant-based omega-3 pioneers, Qualitas Health, DBA iwi, announces it has secured $10 million in venture funds at a $73million post-money valuation. The investment round is being led by world-class foodTech investor PeakBridge VC, Malta, together with Arancia Group, a privately owned Mexico-based food ingredient/food service conglomerate, Minrav (the company s largest investor) and additional private investors. Additional convertible notes held by Minrav Holdings, Sasa, Trucent and other single investors are converted to equity. The investment will accelerate customer acquisition, and commercialization of the company s unique plant-based protein. The funds will also be used to deepen its strong clinical science and IP and accelerate its expansion into additional geographies.
CorNeat Vision s First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Center, Ending a Decade of Blindness
USA - English
News provided by
Share this article
Share this article
RA ANANA, Israel, Jan. 11, 2021 /PRNewswire/ The CorNeat KPro, the first artificial cornea which completely integrates with the eye wall with no reliance on donor tissue, was successfully implanted in a human. The surgery was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor Irit Bahar, Director of the Ophthalmology Department. Upon removal of bandages, the CorNeat KPro immediately enabled the patient to read text and recognize family members. This exciting moment can be viewed in the following link.
Share this article
Share this article
LOS ANGELES, Jan. 11, 2021 /PRNewswire/ The pandemic has hit Americans hard with daunting health concerns, nagging financial fears, and unsettling emotional turmoil. Who hasn t felt some stress and anxiety during the pandemic? MyWellbeing.com, which began in 2017 in New York City and has connected more than 3,000 people with practitioners, launched today in Los Angeles County, with remote online help available across California. The free service, which matches therapy-seekers with a therapist who is a strong fit based on their confidential survey responses, currently has 25 therapists in Los Angeles County on a waiting list ready to begin seeing patients, whether virtually or in-office.